Part 3 Monitoring for indicative dose and analytical performance characteristics United Kingdom 5Monitoring for compliance with the ID 6Screening for certain radionuclides, or screening for an individual radionuclide 7Screening strategies for gross alpha activity and gross beta activity 8Calculation of the ID 9Performance characteristics and methods of analysis Part 3